Earnings Call · Q2 FY2026·2026-07-30

Q2 26EPS -15.97%·Rev n/aQ1 26EPS +35.37%·Rev n/aQ4 25EPS -16.67%·Rev n/aQ3 25EPS +65.71%·Rev n/a⚠ consensus missing

ALNYLAM PHARMACEUTICALS, INC. ALNY

Prilla — Conference Operator

Josh Brodsky — Vice President of Investor Relations

Yvonne Greenstreet — Chief Executive Officer

Jeff Poulton — Chief Financial Officer

Tolga Tanguler — Chief Commercial Officer

Pushkal Garg — Chief Research and Development Officer

−28.3%1d on move date3d−23.1%5d−20.2%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALNY calls or request research access.

More ALNY calls Browse calls Request research access